Literature DB >> 11295173

The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana.

P Hassan1, D Fergusson, K M Grant, J C Mottram.   

Abstract

The Leishmania mexicana CRK3 gene encodes a cdc2-related protein kinase with activity towards histone H1. Attempts to disrupt both alleles of CRK3 in the promastigote life-cycle stage resulted in changes in cell ploidy, which were avoided only when an extra copy of CRK3 was expressed from an episome. This provides strong evidence that CRK3 is essential to L. mexicana. The cyclin-dependent kinase specific inhibitor flavopiridol inhibited affinity purified histidine tagged CRK3 (CRK3his) with an IC(50) value of 100 nM and inhibited in vitro growth of L. mexicana promastigotes. Incubation of promastigotes with 2.5 microM flavopiridol for 24 h led to cell cycle arrest with an accumulation of 95% of cells in G2 or early mitosis (G2/M). Release from cell cycle arrest resulted in a semi-synchronous re-entry into the cell cycle; samples taken at 2, 4, and 6 h after release from the block were enriched for cells in G1 (68%), S-phase (70%), and G2/M phase (61%), respectively. This method of synchronisation was used to show that the majority of CRK3his activity towards the substrate histone H1 was present at G2/M. These data suggest that CRK3 has an essential role in controlling cell cycle progression at the G2/M-phase transition in L. mexicana promastigotes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295173     DOI: 10.1016/s0166-6851(01)00220-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  28 in total

1.  Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178.

Authors:  Felipe C Gomes; Nahla Osman M Ali; Elaine Brown; Roderick G Walker; Karen M Grant; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-03-23       Impact factor: 1.759

2.  Pairwise knockdowns of cdc2-related kinases (CRKs) in Trypanosoma brucei identified the CRKs for G1/S and G2/M transitions and demonstrated distinctive cytokinetic regulations between two developmental stages of the organism.

Authors:  Xiaoming Tu; Ching C Wang
Journal:  Eukaryot Cell       Date:  2005-04

3.  Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.

Authors:  Matthew B Rogers; James D Hilley; Nicholas J Dickens; Jon Wilkes; Paul A Bates; Daniel P Depledge; David Harris; Yerim Her; Pawel Herzyk; Hideo Imamura; Thomas D Otto; Mandy Sanders; Kathy Seeger; Jean-Claude Dujardin; Matthew Berriman; Deborah F Smith; Christiane Hertz-Fowler; Jeremy C Mottram
Journal:  Genome Res       Date:  2011-10-28       Impact factor: 9.043

Review 4.  Protein kinases as drug targets in trypanosomes and Leishmania.

Authors:  Christina Naula; Marilyn Parsons; Jeremy C Mottram
Journal:  Biochim Biophys Acta       Date:  2005-09-08

5.  Drug targets in Leishmania.

Authors:  Bhavna Chawla; Rentala Madhubala
Journal:  J Parasit Dis       Date:  2010-10-08

6.  Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.

Authors:  Karen M Grant; Morag H Dunion; Vanessa Yardley; Alexios-Leandros Skaltsounis; Doris Marko; Gerhard Eisenbrand; Simon L Croft; Laurent Meijer; Jeremy C Mottram
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  Apoptotic marker expression in the absence of cell death in staurosporine-treated Leishmania donovani.

Authors:  Aude L Foucher; Najma Rachidi; Sarah Gharbi; Thierry Blisnick; Philippe Bastin; Iain K Pemberton; Gerald F Späth
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

8.  Inhibition of Eimeria tenella CDK-related kinase 2: From target identification to lead compounds.

Authors:  Kristin Engels; Carsten Beyer; Maria L Suárez Fernández; Frank Bender; Michael Gassel; Gottfried Unden; Richard J Marhöfer; Jeremy C Mottram; Paul M Selzer
Journal:  ChemMedChem       Date:  2010-08-02       Impact factor: 3.466

9.  High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.

Authors:  Roderick G Walker; Graeme Thomson; Kirk Malone; Matthew W Nowicki; Elaine Brown; David G Blake; Nicholas J Turner; Malcolm D Walkinshaw; Karen M Grant; Jeremy C Mottram
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

10.  Developments in diagnosis and antileishmanial drugs.

Authors:  Prachi Bhargava; Rajni Singh
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.